Filing Details
- Accession Number:
- 0001645470-19-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-17 16:35:46
- Reporting Period:
- 2019-05-13
- Accepted Time:
- 2019-05-17 16:35:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-13 | 2,000 | $0.01 | 21,754,897 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 50 | $0.01 | 21,754,947 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 50 | $0.01 | 21,754,997 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 4,900 | $0.01 | 21,759,897 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-13 | 1,500 | $0.01 | 21,761,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 15,000 | $0.01 | 21,776,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 1,000 | $0.01 | 21,777,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 2,000 | $0.01 | 21,779,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 2,000 | $0.01 | 21,781,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 2,000 | $0.01 | 21,783,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-15 | 5,000 | $0.01 | 21,788,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-15 | 2,000 | $0.01 | 21,790,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-15 | 5,000 | $0.02 | 21,795,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,800,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,805,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,810,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,815,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,820,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,825,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $0.01 | 21,830,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 2,000 | $0.01 | 21,832,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 2,000 | $0.01 | 21,834,397 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
